Bragina O. D. Olga Dmitrievna, Chernov V. I. Vladimir Ivanovich, Larkina M. S. Mariya Sergeevna, Rybina A. Anstasiya, Zelchan R. V. Roman Vladimirovich, & Garbukov E. Eugeniy. (2023). Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer. 2023. https://doi.org/10.7150/thno.86770
Chicago Style (17th ed.) CitationBragina O. D. Olga Dmitrievna, Chernov V. I. Vladimir Ivanovich, Larkina M. S. Mariya Sergeevna, Rybina A. Anstasiya, Zelchan R. V. Roman Vladimirovich, and Garbukov E. Eugeniy. Phase I Clinical Evaluation of 99mTc-labeled Affibody Molecule for Imaging HER2 Expression in Breast Cancer. 2023, 2023. https://doi.org/10.7150/thno.86770.
ציטוט MLABragina O. D. Olga Dmitrievna, et al. Phase I Clinical Evaluation of 99mTc-labeled Affibody Molecule for Imaging HER2 Expression in Breast Cancer. 2023, 2023. https://doi.org/10.7150/thno.86770.